Related Experiment Videos
[Restrictive cardiomyopathy]
1Clinique cardiologique et des maladies vasculaires, hôpital G. & R. Laennec, Nantes.
Insights
Restrictive cardiomyopathies, rare heart muscle diseases, involve impaired diastolic filling. Diagnosis can be challenging, requiring various investigations, with treatment focusing on symptom management and complication prevention.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Internal Medicine
Context:
- Restrictive cardiomyopathies are the rarest form of cardiomyopathy, characterized by impaired ventricular filling and reduced diastolic volume.
- These conditions may be idiopathic, familial, or secondary to other diseases like amyloidosis or hypereosinophilic syndrome.
- Clinical presentation often mimics other cardiac conditions, complicating diagnosis.
Purpose:
- To review the characteristics, diagnostic challenges, and management strategies for restrictive cardiomyopathies.
- To highlight the differential diagnosis between restrictive cardiomyopathy and constrictive pericarditis.
- To discuss current and emerging therapeutic approaches, particularly for amyloidosis-associated restrictive cardiomyopathy.
Summary:
- Restrictive cardiomyopathy presents with diastolic dysfunction, normal ventricular wall thickness, and preserved systolic function, often with increased interstitial fibrosis.
- Symptoms include signs of heart failure (except cardiomegaly), thromboembolic events, atrial fibrillation, and atrioventricular block.
- Diagnostic modalities include echocardiography, MRI, CT, and biopsy; treatment involves diuretics, anticoagulants, and management of arrhythmias, with cardiac transplantation as an option for advanced cases.
Impact:
- Improved understanding of restrictive cardiomyopathies aids in earlier diagnosis and more effective patient management.
- Highlights the importance of differentiating from constrictive pericarditis for appropriate treatment selection.
- Emphasizes the need for targeted therapies, especially for specific etiologies like cardiac amyloidosis.
Abstract:
Restrictive cardiomyopathies are the rarest forms of cardiomyopathy. They are characterised by restrictive filling and reduction in diastolic volume of one or both ventricles with normal wall thickness and systolic function. Increased interstitial fibrosis may be observed. This form of cardiomyopathy may be idiopathic or associated with other conditions (amyloid disease, endomyocardial pathology with or without hypereosinophilia). The idiopathic variety is sometimes familial. The symptoms are not specific except for angina in cases of amylosis. All the signs of cardiac failure except cardiomegaly are present in advanced stages. In the idiopathic forms, thromboembolic complications are common. Atrial fibrillation and atrioventricular block are also often observed. The differential diagnosis with chronic constrictive pericarditis is sometimes difficult. Different investigations (Doppler echocardiography, CT scan, magnetic resonance imaging, isotopes, cardiac catheterisation and endomyocardial biopsy) may all fail to make the diagnosis and pericardectomy may have to be performed in the last resort. Treatment is based on diuretics, prevention of atrial fibrillation (amiodarone) and oral anticoagulants. Digoxin, which fixes to amyloid fibrils, may be arrhythmogenic in amyloidosis. Cardiac pacing may be used in cases of atrioventricular block and brady-arrhythmias. Cardiac transplantation is available in advanced forms after exclusion of amyloidosis. New specific therapeutic approaches to amyloidosis are discussed.